Restless legs affect many people with MS, review finds

Credibility

Interest

Share:1 min read

Key Takeaway

A review found that restless legs syndrome is common in people with MS and can disrupt sleep.

What They Found

Restless legs syndrome causes a strong urge to move, usually in the legs. Unpleasant feelings, such as aching or tingling, often come with it. Symptoms tend to worsen while resting and improve during movement, especially in the evening or at night. The review reported restless legs syndrome in about 28% of people with MS. Across the studies reviewed, about 70% of people taking certain nerve-pain medicines reported major improvement, compared with about 40% taking a placebo (an inactive treatment).

Who Should Care and Why

This review covers people with restless legs syndrome, including people with MS. Its findings about treatments are not specific to people with MS. Restless legs symptoms can make it hard to fall asleep or stay asleep. The review also describes how doctors identify the condition from a person's symptoms. It reports that some medicines used for restless legs can make symptoms worse over time.

Important Considerations

You should know this is a review, not a new study testing a treatment in people with MS. The abstract does not give a total number of people included in the studies it reviewed. You cannot tell from this abstract whether the reported treatment results apply equally to people with MS.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Specific Symptoms

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like JAMA often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News